Caszyme is featured in The Medicine Maker!
In this recent article, CEO Monika Paule discusses our collaboration with Integra Therapeutics. She highlights the capabilities and potential of our novel Cas12l nuclease in advancing CRISPR-based solutions.
Read the full article here.